What is the recommended dosage and treatment protocol for ergocalciferol (Vitamin D2) in patients with vitamin D deficiency or insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ergocalciferol (Vitamin D2) Dosing for Vitamin D Deficiency/Insufficiency

For patients with vitamin D deficiency or insufficiency, ergocalciferol (Vitamin D2) should be dosed based on the severity of deficiency, with 50,000 IU weekly for 8-12 weeks being the standard approach for most patients, followed by maintenance therapy. 1

Dosing Protocol Based on Severity

Severe Vitamin D Deficiency (25(OH)D < 5 ng/mL)

  • Initial therapy: 50,000 IU ergocalciferol weekly for 12 weeks 1
  • Maintenance: 50,000 IU monthly after repletion 1
  • Alternative: 8,000 IU/day orally for 4 weeks, then 4,000 IU/day for 2 months 1

Mild Vitamin D Deficiency (25(OH)D 5-15 ng/mL)

  • Initial therapy: 50,000 IU ergocalciferol weekly for 8 weeks 1
  • Maintenance: 50,000 IU monthly after repletion 1
  • Alternative: 4,000 IU/day orally for 12 weeks or 50,000 IU every other week for 12 weeks 1

Vitamin D Insufficiency (25(OH)D 16-30 ng/mL)

  • Initial therapy: 50,000 IU ergocalciferol every 2 weeks for 12 weeks 2
  • Maintenance: 2,000 IU daily or 50,000 IU every 4 weeks 1

Monitoring and Target Levels

  • Check 25(OH)D levels after 3 months of supplementation 2
  • Target 25(OH)D level: ≥30 ng/mL 1, 2
  • Monitor serum calcium in patients at risk for hypercalcemia 2
  • After achieving repletion (25(OH)D ≥30 ng/mL), maintain with 200-1,000 IU daily 1

Special Populations

Chronic Kidney Disease (CKD)

  • For CKD patients, dosing follows the same protocol but requires more careful monitoring 1
  • Higher doses may be more effective in CKD: A study showed that double the K/DOQI recommended dose significantly increased 25(OH)D levels (from 20.99 to 33.41 ng/mL) and decreased PTH levels (from 90.75 to 76.40 pg/mL) 3
  • Important: Do not use calcitriol, alfacalcidol, or other synthetic active vitamin D analogs to treat 25(OH)D deficiency 1

Obese Patients and Malabsorption

  • May require 2-3 times the standard dose 2
  • Consider 50,000-100,000 IU/week for better repletion in these patients 4

Safety Considerations

  • Vitamin D toxicity is rare but can occur with daily doses >50,000 IU that produce 25(OH)D levels >150 ng/mL 2
  • Upper safety limit for 25(OH)D is generally considered 100 ng/mL 2
  • Ergocalciferol has been administered at doses of 10,000 IU daily in CKD patients for over a year without evidence of toxicity 1
  • Case reports document patients receiving much higher doses (e.g., 150,000 IU daily for 28 years) without toxicity, though this is not recommended 5

Practical Administration Tips

  • Take ergocalciferol with food to reduce GI symptoms 2
  • Ensure adequate calcium intake of 1,000-1,200 mg daily from all sources 2
  • If GI symptoms occur, consider splitting the dose or reducing frequency (e.g., 50,000 IU every 2 weeks instead of weekly) 2

Efficacy Considerations

  • Higher doses (100,000 IU/week) achieve optimal 25(OH)D levels more effectively than standard doses (40,000 IU/week), particularly in severe deficiency 6
  • For long-term treatment, dosage should be adjusted by monitoring 25(OH)D levels periodically 7

Remember that hypercalcemia is the primary sign of excessive dosing, and development of this condition would indicate a need to reduce or temporarily discontinue therapy 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.